| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $33.9M | — | +27.2% |
| Cost of Revenue | $18.5M | — | +18.6% |
| Gross Profit | $15.4M | — | +39.4% |
| R&D Expense | $2.6M | — | +5.7% |
| SG&A Expense | $6.1M | — | +5.3% |
| Operating Income | $954K | — | +133.1% |
| Pre-tax Income | $977K | — | +135.0% |
| Income Tax | $188K | — | +140.9% |
| Net Income | $789K | — | +133.9% |
| EPS (Basic) | $0.06 | — | +131.6% |
| EPS (Diluted) | $0.06 | — | +131.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $12.9M | -9.5% | -41.6% |
| Accounts Receivable | $30.2M | +16.5% | +42.4% |
| Inventory | $30.5M | -3.6% | +10.3% |
| Current Assets | $79.6M | +1.3% | +6.3% |
| Total Assets | $150.8M | -0.4% | +1.9% |
| Current Liabilities | $35.8M | +0.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.3M | — | -159.9% |
| Capital Expenditures | $644K | — | +181.2% |
| Investing Cash Flow | -$644K | — | -181.2% |
| Financing Cash Flow | $1.7M | — | +148.9% |
| Free Cash Flow | -$4.0M | — | -174.6% |
| +14.4% |
| Long-term Debt | $1.1M | -20.3% | -83.8% |
| Total Liabilities | $46.3M | -2.9% | -4.8% |
| Stockholders' Equity | $104.5M | +0.8% | +5.1% |